Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.

NCT06489613 is registered in ClinicalTrials.gov with Jian Li as lead sponsor.

NCT NCT06489613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06489613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.
Lead sponsor
Jian Li
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2024
Completion date
June 30, 2025
Enrollment
15,600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

m protein, monoclonal gammopathy, monoclonal gammopathy of undetermined significance